At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 18 enrolled
Drug / intervention
BI 10773 +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Relative Bioavailability of BI 10773 and Simvastatin After Single and Combined Administration - an Open-label, Randomised, Crossover Trial in Healthy Subjects
In Brief
A Phase 1 clinical trial evaluating BI 10773 and simvastatin for Healthy. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The objective of the study is to investigate the drug-drug interaction potential between BI 10773 and simvastatin.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
2011201220132014201520162017201820192020202120222023202420252026
Enrollment StartFeb 2011
First PostedFeb 2011
Primary CompletionApr 2011
TodayJul 2026
First PostedFeb 25, 2011
Enrollment StartFeb 1, 2011
Primary CompletionApr 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 15.4 years ago
Interventions
BI 10773drug
Medium dose oral administration
simvastatindrug
Medium dose oral administration
simvastatindrug
Medium dose oral administration
BI 10773drug
Medium dose oral administration